As health systems around the world consider how to address the issue of burden and burnout, healthcare is looking to artificial intelligence (AI) to optimise processes, streamlining workflo
Clinical trials historically struggled with several key inefficiencies, many of which became painfully apparent during the COVID-19 pandemic, such as the traditional paper-based, manual rev
Supply chain disruptions are taking centre stage in the media landscape at the outset of 2024, with incidents ranging from blockages in the Panama and Suez Canals to escalating geopolitical
On International Women’s Day, pharmaphorum looks back to an interview with data infrastructure and analytics company Kalderos’ CEO Angie Franks, a longtime healthcare executive, speaking wi
Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially.